BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28404968)

  • 1. Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma.
    Song H; Wang L; Lyu J; Wu Y; Guo W; Ren G
    Oncotarget; 2017 Apr; 8(17):29080-29090. PubMed ID: 28404968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.
    Koopmans AE; Verdijk RM; Brouwer RW; van den Bosch TP; van den Berg MM; Vaarwater J; Kockx CE; Paridaens D; Naus NC; Nellist M; van IJcken WF; Kiliç E; de Klein A
    Mod Pathol; 2014 Oct; 27(10):1321-30. PubMed ID: 24633195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma.
    van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M
    Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.
    Glasgow BJ; McCannel TA
    Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
    Shah AA; Bourne TD; Murali R
    Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
    Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
    Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of BAP1 and ATM proteins: Association with AJCC tumor category in uveal melanoma.
    Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
    Ann Diagn Pathol; 2020 Feb; 44():151432. PubMed ID: 31864162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion.
    Shen C; Wang Y; Wei P; Du X
    BMC Cancer; 2016 Aug; 16(1):670. PubMed ID: 27553041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline BAP1 alterations in familial uveal melanoma.
    Rai K; Pilarski R; Boru G; Rehman M; Saqr AH; Massengill JB; Singh A; Marino MJ; Davidorf FH; Cebulla CM; H Abdel-Rahman M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):168-174. PubMed ID: 27718540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome.
    Kashyap S; Jha J; Singh MK; Singh L; Sen S; Kaur J; Bajaj MS; Pushker N
    Clin Transl Oncol; 2020 Sep; 22(9):1472-1480. PubMed ID: 32124242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
    Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
    Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.
    Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z
    Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAP1 expression in cutaneous melanoma: a pilot study.
    Murali R; Wilmott JS; Jakrot V; Al-Ahmadie HA; Wiesner T; McCarthy SW; Thompson JF; Scolyer RA
    Pathology; 2013 Oct; 45(6):606-9. PubMed ID: 24018818
    [No Abstract]   [Full Text] [Related]  

  • 19. The existence of early stage oral mucosal melanoma: A 10-year retrospective analysis of 170 patients in a single institute.
    Wu Y; Wang L; Ma X; Guo W; Ren G
    Oral Oncol; 2018 Dec; 87():70-76. PubMed ID: 30527246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.